Effectiveness and Safety of Vaccines in Special Populations
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Efficacy and Safety".
Deadline for manuscript submissions: 30 March 2025 | Viewed by 942
Special Issue Editors
Interests: key populations; pregnancy; ageing; immune suppression; vaccination
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccines are the most effective tool in combating epidemics and reducing disease. We have seen significant advancements in the development of vaccines, especially during the recent SARS-CoV-2 pandemic. However, clinical trials sometimes do not include particular populations such as pregnant women, the elderly, people living with HIV, and those at high risk of infection due to various factors. Additionally, individuals with limited access to healthcare due to geographical or economic barriers are often not included in these trials, and lactating women may also be omitted from clinical studies. We are inviting original submissions of research, viewpoints, and commentaries to this Special Issue which aims to collect recent evidence on the efficacy and safety of different vaccines in specific populations. We look forward to receiving your contributions.
Dr. Justyna Dominika Kowalska
Prof. Dr. Arjan Harxhi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- special populations
- HIV
- pregnancy
- migrants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
